Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of July 25 Dividend Increases/Decreases for the Week of July 18 Dividend Increases/Decreases for the Week of July 11 Dividend Increases/Decreases for the Week of July 4 Dividend Increases/Decreases for the Week of June 27 Dividend Increases/Decreases for the Week of June 20

Results 71 - 80 of 135 for mye. (0.24 seconds) Novartis: Business Transformation in Progress Image shown: The performance of Novartis’ stock... Johnson & Johnson: Headline Risk But Business Solid We remain big fans of the steady hand displayed by the... Pfizer: Lots of Moving Parts in a Generally-Inspiring Second Quarter Image Source: Pfizer. We came away generally... Stellar Keytruda Growth Powers Merck Higher Shares of pharmaceutical giant Merck continue to... GlaxoSmithKline: Turnaround in Progress? Image Shown: GlaxoSmithKline's share price performance... Changes to the Newsletter Portfolios (Best Ideas & Dividend Growth) Image shown: In our December 26 note to members, we moved... Facebook Was Textbook, Intel Still About Fairly Valued After Weakness Image: Best Ideas Newsletter portfolio holding Facebook's... Johnson & Johnson Revises Sales Guidance Higher Yet Again Image Shown: Johnson & Johnson revised its expected... In the News: Amazon, GE, Kraft-Heinz, Disney, CVS Health, Gilead We're reiterating the large range of fair value outcomes... Biotech and Pharma Roundup Image Source: e-Magine Art. Some big news in the... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | next